Scribd
Upload
62 views

Kiran Mazumdar Shaw: India's Biotech Queen

Kiran Mazumdar Shaw is an Indian entrepreneur who is the founder and executive chairperson of Biocon, India's largest biotechnology company. She has over 40 years of experience in the biotech industry and has led Biocon's growth from a small startup to a major biopharmaceutical company with successful insulin and oncology treatments. Under her leadership, Biocon has become a global company with advanced research facilities and manufacturing plants, and has created thousands of jobs in India. She has received many honors and awards for her contributions to science, business, and society.

Uploaded by

Rising Revolutionary
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd
62 views

Kiran Mazumdar Shaw: India's Biotech Queen

Kiran Mazumdar Shaw is an Indian entrepreneur who is the founder and executive chairperson of Biocon, India's largest biotechnology company. She has over 40 years of experience in the biotech industry and has led Biocon's growth from a small startup to a major biopharmaceutical company with successful insulin and oncology treatments. Under her leadership, Biocon has become a global company with advanced research facilities and manufacturing plants, and has created thousands of jobs in India. She has received many honors and awards for her contributions to science, business, and society.

Uploaded by

Rising Revolutionary
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd
You are on page 1/ 13

Kiran Mazumdar

Shaw

India’s Biotech Queen


Life…
Born on 23rd March, 1953 in Bangalore

Schooling at Bishop Cotton Girls School & Mount Carmel College at


Bangalore

B.Sc in Zoology from Bangalore University

Qualified as a master brewer from Ballarat Universtiy, Australia

CMD, Biocon Ltd., India’s biggest Biotechnology Company

In 2004, she became India’s Richest Woman


Personal Life…
Kiran Mazumdar Shaw is married to John Shaw, a Scotsman and Indophile.

John Shaw headed a leading textiles MNC, Madura Coats from 1991 to 1998
as CMD.

Currently, John Shaw is Vice-Chairman of Biocon, Ltd.

She has huge collections of paintings and other art works.

She has also written a coffee table book named “Ale & Arty”- the story of
Beer.
Experience
1975- 77 worked as a Technical consultant at Jupiter Breweries
limited,Kolkata

Technical manager at Standard Maltings corporation, Baroda

Constraints in making a career in Brewing and malting industry

1978 joined Biocon biochemicals limited in Ireland as Trainee manager

Started Biocon India along with Leslie Auchincloss of Biocon international

Produce industrial enzymes used in maing of alcholic beverages,paper and


other products
Challeges faced
Credibility challenge being a woman entrepreneur and young age

Credibility challenge leads to challenge of not able to get talented


employees. No salaries to pay employees initially

Prejudice of high tech products manufactured in India and there by market


acceptance

Competition from foreign products, SME status in the beginning

Non availbility of infrastructural facility for running a bio tech business


Problem of power suppy, good quality water , sterile labs, quality research
equipments and advanced scietific skills
Journey of Biocon…under her wings..
In 1978, she joined Biocon Biochemicals Limited, of Cork, Ireland as a
Trainee Manager.

In 1978 itself, she started Biocon in he garage in Bangalore with a capital of


Rs. 10,000. First customer UB

Within a year, Biocon became the first Indian company to manufacture and
export enzymes to USA and Europe.

In 1990, she upgraded Biocon’s in-house research program, based on a


proprietary solid substrate fermentation technology. Two research centres
setup

The commercial success of this program led to a three-fold expansion by


1996 and Biocon entered the biopharmaceuticals segments

In 1998, when Unilever agreed to sell its shareholding in Biocon to the


Indian promoters, Biocon became an independent entity.
In 2000, Biocon's proprietary bioreactor, christened PlafractorTM, based on
solid matrix fermentation received a U.S. patent. Bio con transited from
industrial enzym company to biopharmaceuticals.

By 2003 Biocon became the first company worldwide to develop human


insulin on a Pichia expression system.

In 2004, she decided to access the capital markets to develop Biocon’s


pipeline of research programs.

Biocon’s IPO was oversubscribed 32 times and its first day at the bourses
closed with a market value of $1.11 billion.

It made Biocon the 2nd only company to cross $1 billion mark on the first day
of listing.

She entered into more than 2,200 high-value R&D licensing and other deals
within the pharmaceuticals and bio-pharmaceutical space between 2005 &
2010
approach towards employee
• Biocon’s employee-management philosophy
based on ‘respect your employee, every one
has something to contribute’
• Kiran believed in generating employment
for the poor and unskilled labour force
Over coming challenges
• Persistence in her venture
• Innovative ways of overcoming the hurdles
• Passion and energy and determination to make
difference in peoples lives
• Ability to select good people, specially
researchers and build an empowered team
• Modernisation of the plant
• Patenting and collaboration for product
development and commercialisation as most
important source of competitive advantage.
• Today Biocon is global biopharmaceutical
company with a well balanced business
portfolio of products
• Research focus on diabetes, oncology and
auto immune disease
• Asia’s largest insulin and statins
manufacturing facilities.
• Largest perfusion based antibody
production facilities.
Biocon’s Achievement…
Med Ad News, in its 2007/08
Med Ad News, in its 2007/08
listings has ranked Biocon 20th
listings also ranked Biocon as
amongst the leading
7th Largest Employer in the
biotechnology companies in the
world.
world.

• First company to
produce oral insulin

Biocon also received the 2009


BioSingapore Asia Pacific
Biotechnology Award for Best
Listed Company
Personal Achievement…
1982 NATIONAL INSTITUTE OF MARKETING MANAGEMENT, INDIA

1983 ROTARY CLUB, KARNATAKA

1989 PADMASHRI, GOI

1999 INTERNATIONAL WOMENS ASSOCIATION, CHENNAI

2002 ERNST & YOUNG

2005 HIGHEST CIVILIAN HONOURS

2009 EXPRESS PHARMACEUTICAL LEADERSHIP SUMMIT AWARD

2010 FORBES LIST


• she says ‘ success is about doing things in a
differentiated way- dare to be different so
that you stand out’
• Biocon’s tag line ‘The difference lies in our
DNA”

You might also like